Sonova Holding AG, CH0012549785

Sonova stock trades at CHF 248.40 below its yearly high

Published on 10/04/2026 at 12:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonova stock posted FY 2025/26 sales of CHF 3,605.9 million, up 5.9 percent in local currencies. A 19-analyst consensus rates the shares Hold.

A soft watercolor illustration of a Swiss alpine lake surrounded by snow-capped mountains with birds in flight reflected on the calm water surface, gentle concentric sound wave ripples radiating across the lake as stylized acoustic waves, rendered in past
Sonova CH0012549785: Aquarell eines Schweizer Sees mit Vögeln und stilisierten Schallwellen in Pastelltönen, Illustration mit AI erstellt.

Sonova stock was last at CHF 248.40 on the SIX Swiss Exchange on October 2, 2026, 2.89 percent below its 52-week high of CHF 255.80. The latest company announcement dated September 29 ranked Sonova first among Switzerland's 100 largest companies for innovation, according to Sonova International.

Innovation remains the company hook

The ranking follows Sonova's August 24 launch of the Phonak EON hearing-aid portfolio, which uses the HYPERSONIC chip and third-generation real-time artificial intelligence, according to Sonova International. The product cycle gives the company a concrete technology angle while the share price remains close to its yearly peak.

On October 2, the SIX quote showed a daily high of CHF 250.00, a low of CHF 247.00 and trading volume of 70,640 shares. Sonova's year-to-date performance stood at 20.81 percent, compared with the 52-week range of CHF 163.00 to CHF 255.80.

Sales growth supports the valuation

Sonova reported CHF 3,605.9 million in FY 2025/26 sales, an increase of 5.9 percent in local currencies, according to Sonova International. The comparison matters because the company paired top-line growth with increased profitability in the same fiscal year.

For investors, the counterweight is valuation. Sonova's market capitalization was CHF 14.8 billion as of October 3, 2026, while the stock's price-to-earnings ratio was 27.66, according to the quoted market data.

Analysts see limited upside

The analyst picture is cautious despite the innovation narrative. Investing.com lists a Neutral consensus from 19 analysts, with an average 12-month target of CHF 235.68, a high of CHF 350.00 and a low of CHF 170.00. The average target is 5.12 percent below the CHF 248.40 reference price.

Bernstein maintained an Outperform rating and raised its target as hearing-aid recovery gained traction, according to MarketScreener on September 24, 2026. That view contrasts with the broader Hold consensus and leaves the next results release on November 12, 2026 as the next major test of the growth story.

Sonova stock stays near its yearly high

Sonova stock was last at CHF 248.40 on the SIX Swiss Exchange on October 2, 2026 at 5:30 p.m. CEST, down 0.72 percent on the session. The company is valued at CHF 14.8 billion as of October 3, 2026.

Sonova stock facts

  • Company: Sonova Holding AG
  • ISIN: CH0012549785
  • Ticker: SOON
  • Trading venue: SIX Swiss Exchange
  • Price (as of October 2, 2026, 5:30 p.m. CEST): CHF 248.40
  • Market capitalization: CHF 14.8 billion (as of October 3, 2026)
  • 52-week range: CHF 163.00-255.80 (as of October 2, 2026)
  • Sector / Industry: Healthcare / Medical Equipment and Supplies

Upcoming dates for Sonova stock

  • November 12, 2026: Q2 2027 earnings release

More news and analyses on Sonova stock

Disclaimer...

en | CH0012549785 | SONOVA HOLDING AG | boerse | 70224774 | bgmi